Van Lanschot Kempen company information, Employees & Contact Information

Van Lanschot Kempen 2025 AGM decisions and outcomes Van Lanschot Kempen

uniQure Announces $200 Million Proposed Public Offering Yahoo Finance

$345 Million Raised: Gene Therapy Leader uniQure Completes Upsized Offering for AMT-130 Launch Plans Stock Titan

Three European tech awards for private banking innovation Van Lanschot Kempen

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares Yahoo Finance

$200 Million Share Offering: Gene Therapy Leader uniQure Seeks Capital for Transformative Therapies Stock Titan

Arjan Huisman to step down as member of the Management Board Van Lanschot Kempen

Stock Information Evotec

Capital return of €1.40 per share on 26 June 2025 Van Lanschot Kempen

Pharvaris Seeks $150M in Public Offering: Major Push for Late-Stage HAE Drug Development Stock Titan

Thomas Vanderlinden appointed to Management Board Van Lanschot Kempen

Van Lanschot Kempen launches share buy-back programme to fund remuneration policy, share plans and intended acquisition of Accuro Yahoo Finance

First closing of third Europe-focused private equitystrategy Van Lanschot Kempen

uniQure Announces Pricing of Upsized $300 Million Public Offering Yahoo Finance

Van Lanschot Kempen completes share buy-back programme Van Lanschot Kempen

Van Lanschot Kempen announces EGM on capital return proposal Van Lanschot Kempen

Agenda for the 2025 annual general meeting published Van Lanschot Kempen

Van Lanschot Kempen takes note of financial investment by ING in its shares Van Lanschot Kempen

Van Lanschot Kempen announces EGM Van Lanschot Kempen

Van Lanschot Kempen appoints Damla Hendriks as CRO Van Lanschot Kempen

AI assistant for more personal wealth management: Van Lanschot Kempen uses Copilot for Microsoft 365 to foster personal engagement Microsoft

State Street and Van Lanschot Kempen form ETF, client solutions partnership Investment & Pensions Europe

Wendy Winkelhuijzen to succeed Richard Bruens Van Lanschot Kempen

Pharvaris N.V. Announces $150 Million Underwritten Public Offering of Ordinary Shares | PHVS Stock News Quiver Quantitative

Daphne Engelke to be appointed as CEO of Van Lanschot Kempen Switzerland, succeeding Susan Leerkes Van Lanschot Kempen

$300 Million Capital Raise: Gene Therapy Leader uniQure Prices Upsized Public Offering with Warrants Stock Titan

Acquisition of Robeco online investment platform completed Van Lanschot Kempen

Van Lanschot Kempen creates £100m private markets portfolio for DB scheme Investment & Pensions Europe

Van Lanschot Kempen Sole Financial Advisor to PowerField Van Lanschot Kempen

ING to purchase 17.6% stake in Van Lanschot Kempen Private Banker International

Pharvaris N.V. Closes $201.2 Million Upsized Public Offering of Ordinary Shares Quiver Quantitative

Evi van Lanschot proud partner of Olympic champion Marit Bouwmeester Van Lanschot Kempen

People moves: Van Lanschot Kempen adds to fiduciary management team Investment & Pensions Europe

What’s New In Investments, Funds? – Van Lanschot Kempen, Quilter, Pantheon, Saxo WealthBriefing

Pharvaris Secures Massive $201M Public Offering: HAE Drug Developer Sees Strong Investor Demand Stock Titan

ITN Pension Scheme picks Van Lanschot Kempen as fiduciary manager Investment & Pensions Europe

Partner Insight: Roadrunner, Radiohead and Rates - what next for global markets? Professional Pensions

Pharvaris Secures Massive $175M Public Offering to Advance Oral HAE Treatment Pipeline Stock Titan

Van Lanschot Kempen launches private markets portfolio Professional Pensions

Partner Insight: Is there a window of opportunity for well-funded pension schemes to redeploy surplus ? Professional Pensions

Van Lanschot Kempen IM: Funding the future of farming IPE Real Assets

ING buys 17.6% of Van Lanschot Kempen, the Netherlands’ oldest independent bank NL Times